| 000 | 01781nam a2200445 i 4500 | ||
|---|---|---|---|
| 001 | ocn961180535 | ||
| 003 | OCoLC | ||
| 005 | 20170208053814.0 | ||
| 006 | m o d f | ||
| 007 | cr mn||||||||| | ||
| 008 | 161025s2016 dcua o f000 0 eng c | ||
| 040 |
_aGPO _beng _erda _epn _cGPO |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a0445-B-07 (online) | ||
| 086 | 0 | _aHE 1.75:OEI-12-16-00340 | |
| 088 | _aOEI-12-16-00340 | ||
| 099 | _aHE 1.75:OEI-12-16-00340 | ||
| 110 | 1 |
_aUnited States. _bDepartment of Health and Human Services. _bOffice of Inspector General, _eauthor. |
|
| 245 | 1 | 0 | _aCMS should address Medicare's flawed payment system for DME infusion drugs. |
| 246 | 3 | _aCenters for Medicare & Medicaid Services should address Medicare's flawed payment system for DME infusion drugs | |
| 264 | 1 |
_aWashington, D.C. : _bDepartment of Health and Human Services, Office of Inspector General, _c2016. |
|
| 300 |
_a1 online resource (11 pages) : _bcolor illustrations |
||
| 337 | _2rdamedia | ||
| 338 | _2rdacarrier | ||
| 500 | _aTitle from title screen (viewed Oct. 21, 2016). | ||
| 500 | _a"August 2016." | ||
| 500 | _a"OEI-12-16-00340." | ||
| 500 | _a"Report in Brief." | ||
| 500 | _a"HHS OIG Recommendation Followup." | ||
| 500 | _aCRDP Project record. | ||
| 504 | _aIncludes bibliographical references (pages 10-11). | ||
| 650 | 0 |
_aMedicare _xFinance. |
|
| 650 | 0 |
_aInfusion therapy _zUnited States _xEquipment and supplies _xCosts. |
|
| 650 | 0 |
_aDrugs _xFinance _xGovernment policy _zUnited States. |
|
| 610 | 2 | 0 |
_aCenters for Medicare & Medicaid Services (U.S.) _xAuditing. |
| 650 | 0 |
_aWaste in government spending _zUnited States. |
|
| 856 | 4 | 0 | _uhttp://purl.fdlp.gov/GPO/gpo73724 |
| 949 |
_aBEV _bFed Docs |
||
| 999 |
_c257133 _d257133 |
||